New Zealand markets closed

West Pharmaceutical Services, Inc. (WST)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
296.50-0.81 (-0.27%)
At close: 04:00PM EDT
295.50 -1.00 (-0.34%)
After hours: 05:28PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 21.51B
Enterprise value 21.37B
Trailing P/E 42.18
Forward P/E 39.37
PEG ratio (5-yr expected) 5.14
Price/sales (ttm)7.68
Price/book (mrq)8.35
Enterprise value/revenue 7.43
Enterprise value/EBITDA 27.95

Trading information

Stock price history

Beta (5Y monthly) 1.01
52-week change 3-22.57%
S&P500 52-week change 332.65%
52-week high 3413.70
52-week low 3265.00
50-day moving average 3300.82
200-day moving average 3342.30

Share statistics

Avg vol (3-month) 3548.75k
Avg vol (10-day) 3374.17k
Shares outstanding 572.54M
Implied shares outstanding 672.54M
Float 872.06M
% held by insiders 10.58%
% held by institutions 195.83%
Shares short (13 Sept 2024) 41.56M
Short ratio (13 Sept 2024) 44.44
Short % of float (13 Sept 2024) 42.82%
Short % of shares outstanding (13 Sept 2024) 42.15%
Shares short (prior month 15 Aug 2024) 41.26M

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 40.27%
Trailing annual dividend rate 30.79
Trailing annual dividend yield 30.27%
5-year average dividend yield 40.24
Payout ratio 411.24%
Dividend date 307 Aug 2024
Ex-dividend date 431 Jul 2024
Last split factor 22:1
Last split date 327 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 18.25%
Operating margin (ttm)18.45%

Management effectiveness

Return on assets (ttm)10.66%
Return on equity (ttm)19.72%

Income statement

Revenue (ttm)2.88B
Revenue per share (ttm)39.01
Quarterly revenue growth (yoy)-6.90%
Gross profit (ttm)N/A
EBITDA 756.8M
Net income avi to common (ttm)524.9M
Diluted EPS (ttm)7.03
Quarterly earnings growth (yoy)-28.20%

Balance sheet

Total cash (mrq)446.2M
Total cash per share (mrq)6.15
Total debt (mrq)314M
Total debt/equity (mrq)12.19%
Current ratio (mrq)2.34
Book value per share (mrq)35.49

Cash flow statement

Operating cash flow (ttm)752.4M
Levered free cash flow (ttm)172.09M